Joel Moxley

Echelon Capital/Venture capital/ (Echelon Capital) is a Venture Capital firm founded in 2017. The firm is headquartered in Evanston, Wyoming.

InsurTech Gateway Ltd. is an Independent venture capital firm founded in 2016 by Stephen Brittain and Robert Lumley. InsurTech Gateway Ltd. is headquartered in London, UK.

Blue Bear Capital LLC (Blue Bear Capital) is a venture capital firm founded in 2016 by Timothy L. Kopra. The firm is headquartered in Los Angeles, California.

Breakthrough Energy Investment LLC (Breakthrough Energy Ventures) a venture capital arm of Breakthrough Energy LLC was founded in 2016 by Bill Gates. The firm is headquartered in Boston, Massachusetts.

Rho AI develops artificial intelligence-based applications. The private company is based in Charlottesville, VA. The company was founded by Joel Moxley, Erik Allen, Joshua Browne.

Foro Energy, Inc. manufactures and develops lasers for oil, natural gas, geothermal, and mining industries. Its lasers are used to drill, workover, and complete energy wells, including mechanical cutting/grinding, explosives, harsh chemicals and high pressures. The company was founded by Joel F. Moxley, Mark S. Zediker and Mark Land in 2009 and is headquartered in Littleton, CO.

Rubicon Global Holdings LLC engages in the provision of cloud based waste and recycling solutions. It offers recurring dumpster, sustainability reporting, temporary dumpster rental, and waste removal services. It serves the construction and demolition, distribution and logistics, grocery, healthcare, manufacturing, property management, restaurant, and retail industry. The company was founded by Nathaniel R. Morris, Lane B. Moore, Marc Spiegel, Henry M. Dudgeon III, and Hank Dudgeon in 2008 and is headquartered in Atlanta, GA.

Semprus BioSciences, headquartered in Cambridge, Massachusetts, is a venture-backed biomedical company with a dual mission: to provide complication-free medical devices designed to preserve patients' long-term health and quality-of-life and to contribute to healthcare cost efficiencies. Their innovative, multi-faceted approach to durable surface modifications signifies a breakthrough in medical device technology. Their current focus is to enable the first permanently dual-functional (anti-colonization and anti-thrombogenic) vascular access catheter with a single surface modification. Founded out of the Massachusetts Institute of Technology's Langer Lab, the company has developed the next-generation biofunctional surface platform - which is focused on achieving clinical benefits that far exceed current market offerings containing silver, heparin, and antibiotic coatings. Through covalent chemical bonding of their Semprus Surfaces™, a permanent non-leaching biomaterial modification to the device surface, their technology is expected to vastly improve patient outcomes by preventing serious medical complications, such as infection, blood clots, improper healing, and cell overgrowth. They have assembled a world class product development team - scientists, industry executives and clinical experts - who specialize in reducing such complications at the confluence of the human body and implantable devices.